(Q35082473)

6 August 2017

title

Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil™ in adult women (English)

1 reference

6 August 2017

Joaquin Luna

1

1 reference

6 August 2017

Manuel Plata

2

1 reference

6 August 2017

Mauricio Gonzalez

3

1 reference

6 August 2017

Alfonso Correa

4

1 reference

6 August 2017

Ivete Maldonado

5

1 reference

6 August 2017

Claudia Nossa

6

1 reference

6 August 2017

David Radley

7

1 reference

6 August 2017

Scott Vuocolo

8

1 reference

6 August 2017

Richard M Haupt

9

1 reference

6 August 2017

Alfred Saah

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

31 December 2013

1 reference

6 August 2017

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

12

1 reference

6 August 2017

page(s)

e83431

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

copyright license

start time

31 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Prevalence of HPV infection among females in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Epidemiologic classification of human papillomavirus types associated with cervical cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877052

Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24391768

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24391768

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0083431

1 reference

release_ii6vyhjpkbcbteepfyxn5p6ug4

6 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ii6vyhjpkbcbteepfyxn5p6ug4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3877052

1 reference

6 August 2017

1 reference